Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors

Pancreas. 2020 Oct;49(9):1123-1130. doi: 10.1097/MPA.0000000000001658.

Abstract

Patients with neuroendocrine tumors (NETs) and carcinoid syndrome experience diarrhea that can have a debilitating effect on quality of life. Diarrhea also may develop in response to other hormonal syndromes associated with NETs, surgical complications, medical comorbidities, medications, or food sensitivities. Limited guidance on the practical approach to the differential diagnosis of diarrhea in these patients can lead to delays in appropriate treatment. This clinical review and commentary underscore the complexity in identifying the etiology of diarrhea in patients with NETs. Based on our collective experience and expertise, we offer a practical algorithm to guide medical oncologists and other care providers to expedite effective management of diarrhea and related symptoms in patients with NETs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Carcinoid Tumor / complications
  • Carcinoid Tumor / diagnosis
  • Diagnosis, Differential
  • Diarrhea / diagnosis*
  • Diarrhea / etiology
  • Dyspepsia / complications
  • Dyspepsia / diagnosis
  • Gastritis / complications
  • Gastritis / diagnosis
  • Humans
  • Irritable Bowel Syndrome / complications
  • Irritable Bowel Syndrome / diagnosis
  • Neuroendocrine Tumors / complications
  • Neuroendocrine Tumors / diagnosis*
  • Practice Guidelines as Topic*
  • Quality of Life*